Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Buy or not

<< Previous

Bullboard Posts

Next >>

Comment by Captainblkon Feb 25, 2021 12:30pm

100 Views

Post# 32658785

RE:Buy or not

Mick00333 wrote: u said u didnt said u wouldnt buy it but, you said it Now take it like a man and we pass over it everyone thanks you Stop talking like a dog if u want to get out just get out stop posting douch bag post stfu and get out lets the keeper talking here thanks you.

It's posts like This that make me think it's "paid for" pumper and bashers from some third world service where English is barely a requirement.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?